Dark Forest Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Dark Forest Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,267	Closed	-$883K	–	977
2025 Q3	$883K	Sell	7,267 -9,624	-57%	-$1.08M	0.03%	785
2025 Q2	$1.76M	Buy	+16,891	New	+$1.79M	0.07%	502
2023 Q2	–	Sell	-825	Closed	-$50.9K	–	1047
2023 Q1	$50.9K	Buy	+825	New	+$54.2K	0.01%	834
2022 Q1	–	Sell	-141	Closed	-$5K	–	1280
2021 Q4	$5K	Buy	+141	New	+$5.19K	﹤0.01%	1143

Other funds holding AXSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dark Forest Capital Management's AXSM Position: Q4 2025 in Review

Dark Forest Capital Management sold out of Axsome Therapeutics (AXSM) in Q4 2025, closing a stake of 7,267 shares — an estimated $883K sold.

Dark Forest Capital Management first reported a position in AXSM in Q4 2021 and held it in 4 quarters. The position peaked at $1.76M in Q2 2025. 398 funds tracked by Wall St. Rank hold AXSM as of Q4 2025.

Dark Forest Capital Management reported no remaining Axsome Therapeutics position as of Q4 2025 after selling out during the quarter.
Dark Forest Capital Management sold 7,267 Axsome Therapeutics shares in Q4 2025, an estimated $883K.
Dark Forest Capital Management first reported a position in Axsome Therapeutics in Q4 2021 and held it in 4 quarters.
Dark Forest Capital Management's Axsome Therapeutics position peaked at $1.76M in Q2 2025.
398 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2025.

Based on Dark Forest Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.